|
|||||||||||||||||||
![]() |
|||||||||||||||||||
FORWARD TO A FRIEND | SIGN UP FOR THIS AND OTHER CANCER UPDATES |
|
||||||||||||||||||
| Powel Brown, MD, PhD director of Cancer Prevention and Population Sciences Program, Dan L. Duncan Cancer Center; associate director of research, Breast Center; Baylor College of Medicine |
![]() |
A Recap of Last Year's Symposium
The 2006 San Antonio Breast Cancer Symposium sparked a number of important stories, from hormone replacement therapy to data that aided in a new drug's approval. Below are highlights from one year ago, with links provided at the end of each brief to CURE's in-depth coverage of each topic over the past year.
• Tykerb for HER2-Positive Breast Cancer: Herceptin (trastuzumab) is an antibody that targets HER2, a protein present in normal breast cells that is overly abundant in some malignant cells... [MORE]
• Fewer Breast Cancer Cases Linked to Decline in HRT Use: By 2003, millions of women had stopped taking hormone replacement therapy following results from the Women's Health Initiative study that connected estrogen and progestin hormone therapy use to an increased risk of invasive breast cancer... [MORE]
• Zometa Reduces Aromatase Inhibitor-Associated Bone Loss: Aromatase inhibitors can significantly reduce the risk of recurrence in postmenopausal women with early breast cancer... [MORE]
SURVIVOR STORY
Andrea Caruso & Cindy Bell
Paying the Bills for Patients
When Andrea Caruso was diagnosed with stage 1A breast cancer in 2004, her sister, Lynne Shade, wanted to help. But Caruso was in upstate New York and Shade lived in California, so the trick was figuring out how... [MORE]
IN CASE YOU MISSED IT
![]() |
Sculpting a Legacy |
OTHER RELATED COVERAGE
Breast cancer research talks to focus on patients' genetics
(San Antonio Express-News)
Convention: Breast Cancer Symposium
(San Antonio Express-News )
![]()
![]() |
>> Debu Tripathy, MD |
![]() |
>> Kathy LaTour EDITOR-AT-LARGE, CURE & HEAL MAGAZINES The San Antonio Breast Cancer Symposium has grown to more than 8,700 participants. But in 1994, it had reached its first milestone of 1,000 attendees. It was also the year that I first attended the symposium when three of my support group friends offered to accompany me to San Antonio... [MORE] |
![]() |
>> Karen Patterson MANAGING EDITOR, HEAL MAGAZINE Texas journalist and chili meister Frank Tolbert once noted that all Texans have two homes — the city where they live, and San Antonio. That observation applies to the staffs of CURE and Heal as well, given that we are based in Dallas... [MORE] |
|
How has the role of patients and advocates evolved over the past few years in regards to charting standards for clinical care and priorities in breast cancer? [PLAY VIDEO]
| Cheryl Perkins, MD senior medical advisor for Susan G. Komen for the Cure |
![]() |
COMING TOMORROW
Doctors examine a less toxic chemotherapy combination
Targeting breast cancer stem cells
CURE and Heal would like to give a special thanks to the following non-profit partners
for making this information available to their constituents:
American Cancer Society • People Living with Cancer
HER2 Support • Inflammatory Breast Cancer Research Fund • Men Against Breast Cancer
National Breast Cancer Coalition • Pink-Link